BPC-157 dosage & cycles.

What BPC-157 doses do people report taking?

Two published examples are 250 mcg once a day and 250 mcg twice a day. Those are different daily totals: 250 mcg versus 500 mcg. Both accounts describe six-week courses. One is a shoulder-recovery account; the other describes an elbow problem. [1] [2]

These are attributed personal-use examples, not a prescribing recommendation or a survey of the most common dose. Weekly arithmetic assumes seven days.

BPC-157 dosage by body weight

250 mcg and 500 mcg are fixed amounts, not amounts per kilogram. Multiplying either by body weight changes the example completely. For instance, 250 mcg total is 0.25 mg; 250 mcg/kg for an 80 kg person would be 20 mg. These are different instructions, not interchangeable ways to write a dose.

The two accounts above provide fixed amounts and frequencies. They do not supply a tested weight-based adjustment for a lighter or heavier adult. A calculator can convert a chosen amount into volume; it cannot select that amount from body weight. [1] [2]

Reconstituting a 10 mg BPC-157 vial

Reconstitution dissolves powder into liquid. The amount of BPC-157 stays the same; the liquid volume sets the concentration.

Concentration example. Use the preparation volume specified for the actual product.

For a prescribed medicine, use the dispensing pharmacy’s preparation instructions. Cloudiness, particles or a damaged container need assessment before use.

Where are subcutaneous injections given?

Abdominal fatty tissue, the outer upper thighs, and the side or back of the upper arms. These are general sites for prescribed subcutaneous medicines. [6]

Not into a joint, tendon or ligament. A clinician should confirm the route and demonstrate technique for the prescribed product. Injecting next to an injury has not been shown here to work better. [3]

Injection sites for knee or tendon pain

A painful knee or elbow is not automatically the injection site. The published knee-pain series used injections inside the joint at a clinic. It did not compare that procedure with subcutaneous or intramuscular BPC-157, or test whether placing an injection beside an injury works better. The joint procedure should not be copied as a home injection technique. [10]

Morning or evening, empty stomach, and time off

The accounts above establish what those users reported doing; they do not compare morning against evening. Short half-life numbers drawn from animal research also do not establish a human once- versus twice-daily schedule. [3]

BPC-157 half-life

Rats · intravenous

15.2 minutes

Dogs · intravenous

5.27 minutes

Human subcutaneous use

These animal figures do not establish its half-life

Those numbers measured how quickly intact BPC-157 fell in animal plasma after a single intravenous dose. Intramuscular half-lives in the same study also stayed below 30 minutes. A short plasma half-life is not a countdown to take another dose, and it does not measure how long a tissue response lasts. It cannot settle morning versus evening or once versus twice daily in people. [9]

There is no verified fasting instruction in the product specifications reviewed for these capsules. Do not turn an unsupported “empty stomach” rule into a guarantee of better absorption. The relevant questions are the exact formulation and its human data, not whether another product's directions sound familiar.

If something feels wrong, the end of a planned cycle is not a reason to wait. Read the side-effects guide for specific symptoms and actions. If you are comparing BPC alone with Wolverine, the BPC-157/TB-500 blend, calculate each ingredient separately: a blend's total milligrams are not all BPC-157.

For the product comparison and the broader evidence, return to the main BPC-157 peptide guide.

BPC-157 vial calculator

BPC-157 in mL and U-100 units: 5 mg vs 10 mg

On a U-100 syringe, 100 scale units represent 1 mL; 10 units represent 0.1 mL. The mark measures liquid volume. The amount of peptide in that volume changes with the solution concentration.

500 mcg calculation example. Both rows assume 2 mL final volume; the 5 mg row is a strength comparison. The supplied BPC-only vial contains 10 mg.

Copying the same syringe mark between those two solutions doubles or halves the amount. Use mg for the vial, mL for the final solution and mcg or mg for the target. The calculator converts all three together. “Units” here means the U-100 volume scale, not an international unit of BPC-157 activity.

Daily versus weekly dosage: the calculation that matters

250 mcg twice daily means 500 mcg over the whole day. It does not mean dividing 250 mcg into two 125 mcg portions. Over seven days, 500 × 7 = 3,500 mcg, or 3.5 mg.

The five-day column shows arithmetic only; it is not a recommendation for “five on, two off.” A schedule with rest days uses less material. It also creates a different exposure pattern, so it cannot be assumed to have the same effect as daily use.

Write units in full when checking a calculation. 1 mg = 1,000 mcg. Confusing the two creates a thousand-fold error. The symbols mcg and µg both mean micrograms; neither means millilitres.

How long do people cycle BPC-157: four, six or eight weeks?

Six weeks is the duration in the two reports used for the examples above. Four and eight weeks are useful comparisons for understanding how duration changes total quantity. They are not interchangeable “beginner,” “standard” and “advanced” prescriptions.

The tradeoff is straightforward: a longer course means more product, more administration events and longer exposure. It does not automatically mean a better outcome. The reports used here include both improvement and a plateau; they do not compare different cycle lengths in a controlled trial. [1] [2]

Also separate a six-week course from a six-week healing promise. Pain during movement, pain the next morning, range of motion and return to normal training are different outcomes. The before-and-after results include pain scores, recovery timelines and follow-up after stopping.

For ongoing symptoms, repeating a calendar is less informative than reassessing the injury and workload. A better review compares the original problem with the same activity now, including rehabilitation and other treatment. Published evidence does not establish a universal time-off interval between courses. [3]

What changes with the pen, capsules and nasal spray?

The 15 mg pen is already in solution: 3 mL × 5 mg/mL. It avoids powder reconstitution, but its concentration alone does not reveal the amount delivered by one click. The reviewed product information does not publish a per-click calibration. [4]

The spray figures come from the reference label. Confirm the actual bottle before calculating: the current product listing does not repeat the strength. [4]

These are quantities, not route-equivalence claims. A 500 mcg capsule cannot be assumed to deliver the same amount into the bloodstream as a 500 mcg injection. Similarly, adding sprays until their labelled mass looks close to an injected amount does not validate a route conversion. Human absorption data do not establish that substitution. [3]

Oral BPC-157 trials and the results available so far →

How many milligrams, vials or pens does a course represent?

Convert the daily amount to milligrams, multiply by the number of days, then compare that total with the package amount. The products in this set contain 10 mg per vial and 15 mg per pen. [4]

Nominal package arithmetic, rounded up. It excludes priming, transfer losses, unusable residue and storage limits; it is not a purchase or treatment recommendation.

For example, 0.5 mg × 42 days = 21 mg. Two 10 mg vials contain only 20 mg. Three contain 30 mg, leaving a nominal 9 mg after the arithmetic total. That leftover amount is not a reason to extend a course.

A 10 mg vial contains forty 250 mcg portions by mass. A 15 mg pen contains sixty. This does not mean a prepared vial or an opened pen is usable for forty or sixty days: quantity and shelf life are separate. Compare the actual formats in the four-product guide.